XML 67 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share-Based Compensation Plans
12 Months Ended
Dec. 31, 2012
Share-Based Compensation Plans  
Share-Based Compensation Plans

Note 10. Share-Based Compensation Plans

        We grant share-based compensation to our employees and directors. At December 31, 2012, an aggregate of 3,181,161 shares were authorized for future grant under our various share-based compensation plans, including stock options, restricted stock units, and restricted stock awards. Awards that expire or are canceled without delivery of shares generally become available for issuance under the plans. Upon exercises of stock options, vesting of restricted stock units, and vesting of restricted shares under all of our stock plans, we issue new shares of Reliance common stock.

Stock Options

        Stock option activity under all the plans is as follows:

Stock Options
  Option
Shares
  Weighted Average
Exercise Price
  Weighted Average
Remaining
Contractual Term
(In years)
  Aggregate
Intrinsic Value
(In millions)
 

Outstanding at December 31, 2009

    3,809,229   $ 41.22              

Granted

    1,039,400     42.89              

Exercised

    (827,452 )   25.68              

Expired or forfeited

    (141,125 )   47.10              
                   

Outstanding at December 31, 2010

    3,880,052     44.76              

Granted

    1,037,250     55.73              

Exercised

    (266,392 )   41.60              

Expired or forfeited

    (135,350 )   47.57              
                   

Outstanding at December 31, 2011

    4,515,560     47.39              

Exercised

    (1,018,010 )   41.40              

Expired or forfeited

    (92,050 )   49.55              
                   

Outstanding at December 31, 2012

    3,405,500   $ 49.12     3.6   $ 44.4  
                   

Exercisable at December 31, 2012

    2,028,387   $ 49.67     3.0   $ 25.4  
                   

        All options outstanding at December 31, 2012 had four-year vesting periods and seven year terms, with the exception of 186,000 options granted to our non-employee directors that had one-year vesting periods and 207,180 options that had ten-year terms.

        The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model using the following weighted average assumptions:

 
  Year Ended
December 31,
 
 
  2011   2010  

Weighted average assumptions used:

             

Exercise price

  $ 55.73   $ 42.89  

Risk free interest rate

    2.20 %   2.35 %

Expected life in years

    4.8     4.8  

Expected volatility

    60 %   60 %

Expected dividend yield

    0.86 %   0.93 %

Grant date fair value

  $ 26.98   $ 20.62  

        The total intrinsic values of all options exercised during the years ended December 31, 2012, 2011 and 2010 were $15.5 million, $3.4 million and $16.6 million, respectively.

        A summary of the status of our non-vested stock options as of December 31, 2012 and changes during the year then ended is as follows:

Non-vested Options
  Shares   Weighted
Average Grant
Date Fair Value
 

Non-vested at January 1, 2012

    2,369,525   $ 22.28  

Forfeited

    (64,425 ) $ 22.29  

Vested

    (927,987 ) $ 20.90  
           

Non-vested at December 31, 2012

    1,377,113   $ 23.21  
           

        Proceeds from option exercises under all stock option plans for the years ended December 31, 2012, 2011 and 2010 were $42.1 million, $11.1 million and $21.2 million, respectively. The tax benefit realized from option exercises during the years ended December 31, 2012, 2011 and 2010 were $5.4 million, $1.3 million and $6.3 million, respectively.

        The following tabulation summarizes certain information concerning outstanding and exercisable options as of December 31, 2012:

 
   
  Options Outstanding   Options Exercisable  
Range of
Exercise Price
  Outstanding at
December 31, 2012
  Weighted Average
Remaining
Contractual Life
in Years
  Weighted
Average
Exercise Price
  Exercisable at
December 31, 2012
  Weighted Average
Exercise
Price of Options
Exercisable
 
$15 - $19     18,000     2.4   $ 18.31     18,000   $ 18.31  
$24 - $28     21,180     2.5   $ 25.17     21,180   $ 25.17  
$33 - $38     446,450     3.6   $ 34.05     247,275   $ 34.33  
$42 - $45     1,055,235     3.5   $ 43.44     604,085   $ 43.91  
$55 - $57     1,798,635     3.7   $ 56.23     1,071,847   $ 56.58  
$61 - $67     66,000     4.9   $ 64.03     66,000   $ 64.03  
                       
$15 - $67     3,405,500     3.6   $ 49.12     2,028,387   $ 49.67  
                       

Restricted Shares

        On February 26, 2013 and March 16, 2012, we granted 324,780 and 391,050, respectively, restricted stock units ("RSUs") to key employees pursuant to the Amended and Restated Stock Option and Restricted Stock Plan. Each RSU consists of the right to receive one share of our common stock and dividend equivalent rights, subject to forfeiture, equal to the accrued cash or stock dividends where the record date for such dividends is after the grant date but before the shares vest. Additionally, each 2013 and 2012 RSU granted has a service condition and cliff vests at December 31, 2015 and December 31, 2014, respectively, if the recipient is an employee on the vesting date. In addition to the service criteria, 134,725 and 138,700 of the RSUs granted in 2013 and 2012, respectively, also have performance goals and vest only upon the satisfaction of the service and performance criteria. The fair value of the 2013 and 2012 RSUs granted was $65.73 per share and $57.42 per share, respectively, determined based on the closing price of our common stock on the grant date.

        On August 8, 2011 and July 26, 2010, we granted 86,000 and 61,000 shares, respectively, of restricted stock to certain officers of the Company. The awards include dividend rights and vest over five years. The fair value of the 2011 and 2010 restricted stock grants was $37.29 per share and $41.24 per share, respectively, determined based on the closing price of our common stock on the grant date. As of December 31, 2012, 105,400 of these shares remain unvested and outstanding.

        On May 18, 2011, our shareholders approved the Directors Equity Plan, which replaced the Directors Stock Option Plan, and pursuant to the Directors Equity Plan, 16,079 shares of restricted stock were automatically granted to the non-employee members of the Board of Directors on that date. The awards include dividend rights and vest immediately upon grant. The recipients are restricted from trading the restricted stock for one year from date of grant. The fair value of the restricted stock granted was $52.24 per share, determined based on the closing price our common stock on the grant date. On May 16, 2012 16,842 shares of restricted stock were automatically granted to the non-employee members of the Board of Directors. The fair value of the restricted stock granted was $49.87 per share, the closing price of our common stock on the grant date.

        A summary of the status of our non-vested restricted stock grants and RSUs as of December 31, 2012 and changes during the year then ended is as follows:

Non-vested Options
  Shares   Weighted
Average Grant
Date Fair Value
 

Non-vested at January 1, 2012

    134,800   $ 38.72  

Granted

    407,892   $ 57.11  

Vested

    (46,242 ) $ 42.91  
           

Non-vested at December 31, 2012

    496,450   $ 53.44  
           

Unrecognized Compensation Cost

        As of December 31, 2012, there was approximately $38.4 million of total unrecognized compensation cost related to non-vested share-based compensation awards granted under all share-based compensation plans. That cost is expected to be recognized over a weighted average period of 1.53 years.